We are delighted to host an insightful ATTC network webinar this April 2026.
Over recent years, there has been rapid growth in the clinical development pipeline for CAR T therapies in autoimmune indications. These trials introduce new and complex challenges for the sector, including the need for shared care delivery pathways and coordinated clinical infrastructure.
To ensure the UK remains at the forefront of delivering these innovative therapies, continued development of NHS workforce capability and infrastructure is essential. A key part of this is enabling the effective sharing of best practice and operational learning across clinical sites.
In response, the ATTC network is hosting a webinar that brings together leading NHS organisations, including University College London Hospital NHS Foundation Trust, King’s College Hospital NHS Foundation Trust, Manchester University NHS Foundation Trust, and NHS Greater Glasgow and Clyde.
This 90-minute session will feature four case study presentations from experienced clinical sites, highlighting how they have developed local capability and infrastructure to support CAR T trials in autoimmune indications. The session will conclude with a panel discussion, offering further reflections and practical insights into different delivery models, operational structures, and implementation approaches.
Agenda
13:00 - 13:05 | Welcome and introduction
13:05 - 13:55 | Case study presentations from NHS clinical sites
13:55 - 14:25 | Panel discussion and audience Q&A
Chaired by Emily Merrell, Director of ATTC Network Coordination
14:25 - 14:30 | Closing remarks
Who should attend?
• Clinical leads and healthcare professionals involved in cell and gene therapy delivery
• NHS service managers and operational leads
• Pharmacy and advanced therapy specialists
• Research nurses and clinical trial delivery teams
• Workforce development and infrastructure planning stakeholders